share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer LEUNG SANDRA

SEC announcement ·  Mar 12 21:50
Summary by Moomoo AI
On March 10, 2024, Sandra Leung, EVP and General Counsel of Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Leung acquired a total of 46,784 shares through the exercise of derivative securities at no cost. Concurrently, she disposed of 30,813 shares, with a portion of the transactions used to cover exercise prices or tax liabilities at a price of $53.79 per share, resulting in a total market value of $896,141.40. After these transactions, Leung's direct holdings in Bristol-Myers Squibb amounted to 347,385.333 shares. Additionally, she has an indirect beneficial ownership of 100,721.12 shares through a Savings and Investment Program and a Trust (SLAT).
On March 10, 2024, Sandra Leung, EVP and General Counsel of Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Leung acquired a total of 46,784 shares through the exercise of derivative securities at no cost. Concurrently, she disposed of 30,813 shares, with a portion of the transactions used to cover exercise prices or tax liabilities at a price of $53.79 per share, resulting in a total market value of $896,141.40. After these transactions, Leung's direct holdings in Bristol-Myers Squibb amounted to 347,385.333 shares. Additionally, she has an indirect beneficial ownership of 100,721.12 shares through a Savings and Investment Program and a Trust (SLAT).
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more